Total Payments
$2,563
2024 Payments
$261.99
Companies
24
Transactions
140
Medicare Patients
3,534
Medicare Billing
$257,017
Payment Breakdown by Category
Food & Beverage$2,558 (99.8%)
Education$5.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,558 | 139 | 99.8% |
| Education | $5.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $472.73 | 34 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $389.04 | 23 | $0 (2024) |
| Novo Nordisk Inc | $280.28 | 11 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $182.56 | 10 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $161.37 | 8 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $110.32 | 6 | $0 (2023) |
| Mylan Specialty L.P. | $104.52 | 1 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $101.76 | 5 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $100.87 | 7 | $0 (2023) |
| AbbVie Inc. | $97.05 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $261.99 | 15 | Lilly USA, LLC ($211.69) |
| 2023 | $387.02 | 27 | Lilly USA, LLC ($143.07) |
| 2022 | $235.56 | 13 | Novo Nordisk Inc ($47.73) |
| 2021 | $208.82 | 12 | Takeda Pharmaceuticals U.S.A., Inc. ($92.44) |
| 2020 | $272.99 | 15 | Allergan, Inc. ($42.82) |
| 2019 | $294.84 | 6 | Novo Nordisk Inc ($120.37) |
| 2018 | $391.85 | 21 | AstraZeneca Pharmaceuticals LP ($134.89) |
| 2017 | $509.87 | 31 | AstraZeneca Pharmaceuticals LP ($194.40) |
All Payment Transactions
140 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/01/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $8.91 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Diabetes | ||||||
| 08/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: Diabetes | ||||||
| 08/09/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $6.97 | General |
| 06/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $36.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $6.89 | General |
| Category: Diabetes | ||||||
| 04/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $7.63 | General |
| Category: Diabetes | ||||||
| 02/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $7.25 | General |
| Category: Diabetes | ||||||
| 02/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $9.15 | General |
| Category: Diabetes | ||||||
| 02/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $112.36 | General |
| Category: Diabetes | ||||||
| 01/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: Diabetes | ||||||
| 01/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $7.07 | General |
| Category: Diabetes | ||||||
| 12/18/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Gastroenterology | ||||||
| 12/08/2023 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $5.94 | General |
| Category: Diabetes | ||||||
| 12/05/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $7.32 | General |
| Category: Diabetes | ||||||
| 11/16/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Oncology | ||||||
| 11/16/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $9.51 | General |
| Category: Diabetes | ||||||
| 11/09/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $7.15 | General |
| Category: Diabetes | ||||||
| 10/24/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Diabetes | ||||||
| 10/11/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $7.16 | General |
| Category: Diabetes | ||||||
| 10/11/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $3.57 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 654 | 1,129 | $140,868 | $51,546 |
| 2022 | 18 | 849 | 1,631 | $206,159 | $73,127 |
| 2021 | 22 | 1,091 | 1,805 | $191,642 | $77,861 |
| 2020 | 16 | 940 | 1,498 | $159,542 | $54,483 |
Total Patients
3,534
Total Services
6,063
Medicare Billing
$257,017
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 87 | 139 | $34,889 | $11,997 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 187 | $33,099 | $11,085 | 33.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 71 | 71 | $18,034 | $8,774 | 48.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 79 | 129 | $22,833 | $6,875 | 30.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 51 | 70 | $17,430 | $5,392 | 30.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 125 | 303 | $3,738 | $2,185 | 58.4% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2023 | 12 | 14 | $3,990 | $1,957 | 49.0% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 33 | 34 | $1,632 | $1,135 | 69.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 35 | 38 | $1,292 | $1,121 | 86.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 14 | 18 | $1,980 | $639.45 | 32.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 35 | $1,715 | $312.33 | 18.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 17 | 23 | $184.00 | $50.60 | 27.5% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 12 | 68 | $51.68 | $22.45 | 43.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 108 | 265 | $47,435 | $15,101 | 31.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 84 | 130 | $32,760 | $11,579 | 35.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 112 | 215 | $38,270 | $11,521 | 30.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 90 | 90 | $23,130 | $11,365 | 49.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 76 | 118 | $29,736 | $8,673 | 29.2% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2022 | 25 | 28 | $8,008 | $3,927 | 49.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 14 | 16 | $8,752 | $3,250 | 37.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 22 | 37 | $4,070 | $1,361 | 33.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 22 | 34 | $3,808 | $1,111 | 29.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 16 | 26 | $2,340 | $1,110 | 47.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 139 | 347 | $2,082 | $1,020 | 49.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 36 | 81 | $2,415 | $863.28 | 35.7% |
About Dr. Martha Cano, MD
Dr. Martha Cano, MD is a Family Medicine healthcare provider based in Weslaco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2008. The National Provider Identifier (NPI) number assigned to this provider is 1861651598.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Martha Cano, MD has received a total of $2,563 in payments from pharmaceutical and medical device companies, with $261.99 received in 2024. These payments were reported across 140 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,558).
As a Medicare-enrolled provider, Cano has provided services to 3,534 Medicare beneficiaries, totaling 6,063 services with total Medicare billing of $257,017. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Weslaco, TX
- Active Since 06/06/2008
- Last Updated 07/21/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1861651598
Products in Payments
- FARXIGA (Drug) $376.95
- MOUNJARO (Drug) $358.66
- TRINTELLIX (Drug) $142.04
- Xultophy 100/3.6 (Drug) $120.37
- VRAYLAR (Drug) $114.38
- JARDIANCE (Drug) $107.70
- Yupelri (Drug) $104.52
- INVOKANA (Drug) $103.89
- Ozempic (Drug) $103.32
- XIFAXAN (Drug) $100.87
- Peripheral Orbital Atherectomy System (Device) $90.44
- EMGALITY (Drug) $55.62
- Trintellix (Drug) $49.48
- Cologuard Collection Kit (Device) $46.10
- SOLIQUA 100/33 (Biological) $41.55
- CHANTIX (Drug) $38.84
- Vascepa (Drug) $37.37
- XARELTO (Drug) $36.33
- Dexilant (Drug) $34.77
- Rybelsus (Drug) $32.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Weslaco
Melecia Fuentes, M.d, M.D
Family Medicine — Payments: $7,400
Family Medicine $7,400
Dr. Alejandro Fuentes, M.d, M.D
Family Medicine — Payments: $5,116
Family Medicine $5,116
Dr. Donna Mery, M.d, M.D
Family Medicine — Payments: $4,323
Family Medicine $4,323
Dr. Roger Heredia, M.d, M.D
Family Medicine — Payments: $3,405
Family Medicine $3,405
Larissa Riojas, Do, DO
Family Medicine — Payments: $3,282
Family Medicine $3,282
Pamela Ramirez Stroman, M.d, M.D
Family Medicine — Payments: $2,176
Family Medicine $2,176